Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223454

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223454

Global Fecal Occult Blood Tests Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 551 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 4800
PDF (Enterprise License) - Printable/Downloadable
USD 7000

Add to Cart

Description

Table of Contents

List of Tables

Global fecal occult blood testing market is projected to register a substantial CAGR of 5.3 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Global Fecal Occult Blood Tests Market, By Test Type (Lateral Flow Immuno-Fob Test Kits, Immuno-FOB Agglutination Test Kits, Immuno-FOB ELISA Test Kits, Guaiac FOB Stool Test, Flushable Reagent Pad or Tissue, and Others), By Application (Colorectal Cancer Screening, Concern for Gastrointestinal Bleeding, Polyps, Diverticulosis, Ulcers, Haemorrhoids, Colitis, Anemia, and Others), By End User (Diagnostic Laboratories, Hospitals, Speciality Clinics, and Others), By Distribution Channel (Direct Sales, Retail Sales, E-Commerce, and Others), Region (Global, Europe, Asia-Pacific, South America, and Middle East and Africa), Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Global fecal occult blood testing market are:

Rising cases of colorectal cancer globally

Development of direct-to-consumer laboratory testing

Increasing inclination towards point-of-care diagnostics

Easy availability of fecal occult immunological test devices in online stores

Market Players

Some of the key market players for the global fecal occult blood testing market are listed below:

Quidel Corporation

Siemens Healthcare GmbH

Biohit Oyj

Accubiotech Co.Ltd.

Accuquik Test Kits

Aidian

Alfa Scientific Designs, Inc.

Apacor Limited

Others

Show more

TABLE OF CONTENTS

1 INTRODUCTION 75

  • 1.1 OBJECTIVES OF THE STUDY 75
  • 1.2 MARKET DEFINITION 75
  • 1.3 OVERVIEW OF THE GLOBAL FECAL OCCULT BLOOD TESTS MARKET 75
  • 1.4 CURRENCY AND PRICING 77
  • 1.5 LIMITATIONS 77
  • 1.6 MARKETS COVERED 77

2 MARKET SEGMENTATION 81

  • 2.1 MARKETS COVERED 81
  • 2.2 GEOGRAPHICAL SCOPE 82
  • 2.3 YEARS CONSIDERED FOR THE STUDY 83
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 84
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 87
  • 2.6 MULTIVARIATE MODELLING 88
  • 2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 88
  • 2.8 MARKET APPLICATION COVERAGE GRID 89
  • 2.9 DBMR MARKET POSITION GRID 90
  • 2.10 VENDOR SHARE ANALYSIS 91
  • 2.11 SECONDARY SOURCES 92
  • 2.12 ASSUMPTIONS 92

3 EXECUTIVE SUMMARY 93

4 PREMIUM INSIGHTS 95

  • 4.1 PESTEL ANALYSIS 98
  • 4.2 PORTER'S 5 FORCES 99

5 INDUSTRY INSIGHTS 100

6 REGULATORY FRAMEWORK 102

  • 6.1 REGULATORY SCENARIO BY U.S. FDA 102
  • 6.2 REGULATORY SCENARIO IN U.S. 102
  • 6.3 REGULATORY SCENARIO IN EUROPE 103
  • 6.4 REGULATORY SCENARIO IN CANADA 103
  • 6.5 REGULATORY SCENARIO IN AUSTRALIA 103

7 MARKET OVERVIEW 104

  • 7.1 DRIVERS 106
    • 7.1.1 RISING CASES OF COLORECTAL CANCER GLOBALLY 106
    • 7.1.2 DEVELOPMENT OF DIRECT-TO-CONSUMER LABORATORY TESTING 106
    • 7.1.3 EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES 107
    • 7.1.4 INCREASING INCLINATION TOWARDS POINT-OF-CARE DIAGNOSTICS 107
  • 7.2 RESTRAINTS 107
    • 7.2.1 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES 107
    • 7.2.2 LOW AWARENESS ABOUT FECAL OCCULT BLOOD TESTS IN UNDEVELOPED COUNTRIES 108
  • 7.3 OPPORTUNITIES 108
    • 7.3.1 INCREASE IN SCREENING PROCEDURES 108
    • 7.3.2 RISING TECHNICAL ADVANCEMENTS 109
    • 7.3.3 STRATEGIC INITIATIVES 109
  • 7.4 CHALLENGES 110
    • 7.4.1 LACK OF SKILLED PROFESSIONALS 110
    • 7.4.2 LOW EFFICIENCY 110

8 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE 111

  • 8.1 OVERVIEW 112
  • 8.2 LATERAL FLOW IMMUNO-FOB TEST KITS 115
  • 8.3 IMMUNO-FOB AGGLUTINATION TEST KITS 115
  • 8.4 IMMUNO-FOB ELISA TEST KITS 116
  • 8.5 GUAIAC FOB STOOL TEST 117
    • 8.5.1 KITS 118
      • 8.5.1.1 GUAIAC SLIDES 118
        • 8.5.1.1.1 25 PACKAGE 118
        • 8.5.1.1.2 20 PACKAGE 118
        • 8.5.1.1.3 OTHERS 118
      • 8.5.1.2 ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER 119
        • 8.5.1.2.1 SENSITIVITY IS 50NG/ML 119
        • 8.5.1.2.1.1 25 PACKAGE 119
        • 8.5.1.2.1.2 20 PACKAGE 119
        • 8.5.1.2.1.3 OTHERS 120
        • 8.5.1.2.2 SENSITIVITY IS 75NG/ML 120
        • 8.5.1.2.2.1 25 PACKAGE 120
        • 8.5.1.2.2.2 20 PACKAGE 120
        • 8.5.1.2.2.3 OTHERS 120
        • 8.5.1.2.3 OTHERS 120
      • 8.5.1.3 OTHERS 121
    • 8.5.2 REAGENTS 121
      • 8.5.2.1 HYDROGEN PEROXIDE 121
      • 8.5.2.2 OTHERS 121
  • 8.6 FLUSHABLE REAGENT PAD OR TISSUE 121
  • 8.7 OTHERS 122

9 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION 123

  • 9.1 OVERVIEW 124
  • 9.2 COLORECTAL CANCER SCREENING 127
    • 9.2.1 LATERAL FLOW IMMUNO-FOB TEST KITS 128
    • 9.2.2 IMMUNO-FOB AGGLUTINATION TEST KITS 128
    • 9.2.3 IMMUNO-FOB ELISA TEST KITS 128
    • 9.2.4 GUAIAC FOB STOOL TEST 128
    • 9.2.5 FLUSHABLE REAGENT PAD OR TISSUE 128
    • 9.2.6 OTHERS 128
  • 9.3 CONCERN FOR GASTROINTESTINAL BLEEDING 128
    • 9.3.1 LATERAL FLOW IMMUNO-FOB TEST KITS 129
    • 9.3.2 IMMUNO-FOB AGGLUTINATION TEST KITS 129
    • 9.3.3 IMMUNO-FOB ELISA TEST KITS 129
    • 9.3.4 GUAIAC FOB STOOL TEST 130
    • 9.3.5 FLUSHABLE REAGENT PAD OR TISSUE 130
    • 9.3.6 OTHERS 130
  • 9.4 POLYPS 130
    • 9.4.1 LATERAL FLOW IMMUNO-FOB TEST KITS 131
    • 9.4.2 IMMUNO-FOB AGGLUTINATION TEST KITS 131
    • 9.4.3 IMMUNO-FOB ELISA TEST KITS 131
    • 9.4.4 GUAIAC FOB STOOL TEST 131
    • 9.4.5 FLUSHABLE REAGENT PAD OR TISSUE 131
    • 9.4.6 OTHERS 131
  • 9.5 DIVERTICULOSIS 132
    • 9.5.1 LATERAL FLOW IMMUNO-FOB TEST KITS 133
    • 9.5.2 IMMUNO-FOB AGGLUTINATION TEST KITS 133
    • 9.5.3 IMMUNO-FOB ELISA TEST KITS 133
    • 9.5.4 GUAIAC FOB STOOL TEST 133
    • 9.5.5 FLUSHABLE REAGENT PAD OR TISSUE 133
    • 9.5.6 OTHERS 133
  • 9.6 ULCERS 133
    • 9.6.1 LATERAL FLOW IMMUNO-FOB TEST KITS 134
    • 9.6.2 IMMUNO-FOB AGGLUTINATION TEST KITS 134
    • 9.6.3 IMMUNO-FOB ELISA TEST KITS 134
    • 9.6.4 GUAIAC FOB STOOL TEST 135
    • 9.6.5 FLUSHABLE REAGENT PAD OR TISSUE 135
    • 9.6.6 OTHERS 135
  • 9.7 HAEMORRHOIDS 135
    • 9.7.1 LATERAL FLOW IMMUNO-FOB TEST KITS 136
    • 9.7.2 IMMUNO-FOB AGGLUTINATION TEST KITS 136
    • 9.7.3 IMMUNO-FOB ELISA TEST KITS 136
    • 9.7.4 GUAIAC FOB STOOL TEST 136
    • 9.7.5 FLUSHABLE REAGENT PAD OR TISSUE 136
    • 9.7.6 OTHERS 136
  • 9.8 COLITIS 137
    • 9.8.1 LATERAL FLOW IMMUNO-FOB TEST KITS 138
    • 9.8.2 IMMUNO-FOB AGGLUTINATION TEST KITS 138
    • 9.8.3 IMMUNO-FOB ELISA TEST KITS 138
    • 9.8.4 GUAIAC FOB STOOL TEST 138
    • 9.8.5 FLUSHABLE REAGENT PAD OR TISSUE 138
    • 9.8.6 OTHERS 138
  • 9.9 ANEMIA 138
    • 9.9.1 LATERAL FLOW IMMUNO-FOB TEST KITS 139
    • 9.9.2 IMMUNO-FOB AGGLUTINATION TEST KITS 139
    • 9.9.3 IMMUNO-FOB ELISA TEST KITS 139
    • 9.9.4 GUAIAC FOB STOOL TEST 140
    • 9.9.5 FLUSHABLE REAGENT PAD OR TISSUE 140
    • 9.9.6 OTHERS 140
  • 9.10 OTHERS 140

10 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY END USER 141

  • 10.1 OVERVIEW 142
  • 10.2 DIAGNOSTIC LABORATORIES 145
  • 10.3 HOSPITALS 145
  • 10.4 SPECIALITY CLINICS 146
  • 10.5 OTHERS 147

11 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL 148

  • 11.1 OVERVIEW 149
  • 11.2 DIRECT TENDER 152
  • 11.3 RETAIL SALE 152
  • 11.4 E-COMMERCE 153
  • 11.5 OTHERS 154

12 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY REGION 155

  • 12.1 OVERVIEW 156
  • 12.2 NORTH AMERICA 161
    • 12.2.1 U.S. 174
    • 12.2.2 CANADA 182
    • 12.2.3 MEXICO 190
  • 12.3 ASIA-PACIFIC 198
    • 12.3.1 CHINA 211
    • 12.3.2 JAPAN 219
    • 12.3.3 INDIA 227
    • 12.3.4 AUSTRALIA 235
    • 12.3.5 SOUTH KOREA 243
    • 12.3.6 THAILAND 252
    • 12.3.7 SINGAPORE 260
    • 12.3.8 INDONESIA 268
    • 12.3.9 MALAYSIA 277
    • 12.3.10 PHILIPPINES 286
    • 12.3.11 REST OF ASIA-PACIFIC 295
  • 12.4 EUROPE 296
    • 12.4.1 GERMANY 311
    • 12.4.2 FRANCE 321
    • 12.4.3 U.K. 331
    • 12.4.4 ITALY 341
    • 12.4.5 SPAIN 351
    • 12.4.6 RUSSIA 361
    • 12.4.7 SWITZERLAND 371
    • 12.4.8 NETHERLANDS 381
    • 12.4.9 TURKEY 391
    • 12.4.10 BELGIUM 401
    • 12.4.11 REST OF EUROPE 411
  • 12.5 SOUTH AMERICA 412
    • 12.5.1 BRAZIL 427
    • 12.5.2 ARGENTINA 437
    • 12.5.3 REST OF SOUTH AMERICA 447
  • 12.6 MIDDLE EAST AND AFRICA 448
    • 12.6.1 SOUTH AFRICA 463
    • 12.6.2 SAUDI ARABIA 473
    • 12.6.3 U.A.E. 483
    • 12.6.4 EGYPT 493
    • 12.6.5 ISRAEL 503
    • 12.6.6 REST OF MIDDLE EAST AND AFRICA 513

13 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: COMPANY LANDSCAPE 514

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL 514
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 515
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE 516
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 517

14 SWOT ANALYSIS 518

15 COMPANY PROFILE 519

  • 15.1 QUIDEL CORPORATION 519
    • 15.1.1 COMPANY SNAPSHOT 519
    • 15.1.2 REVENUE ANALYSIS 519
    • 15.1.3 COMPANY SHARE ANALYSIS 520
    • 15.1.4 PRODUCT PORTFOLIO 520
    • 15.1.5 RECENT DEVELOPMENT 520
  • 15.2 WONDFO. 521
    • 15.2.1 COMPANY SNAPSHOT 521
    • 15.2.2 COMPANY SHARE ANALYSIS 521
    • 15.2.3 PRODUCT PORTFOLIO 522
    • 15.2.4 RECENT DEVELOPMENT 522
  • 15.3 SIEMENS HEALTHCARE GMBH 523
    • 15.3.1 COMPANY SNAPSHOT 523
    • 15.3.2 REVENUE ANALYSIS 523
    • 15.3.3 COMPANY SHARE ANALYSIS 524
    • 15.3.4 RODUCT PORTFOLIO 524
    • 15.3.5 RECENT DEVELOPMENT 524
  • 15.4 EIKEN CHEMICAL CO., LTD. 525
    • 15.4.1 COMPANY SNAPSHOT 525
    • 15.4.2 REVENUE ANALYSIS 525
    • 15.4.3 COMPANY SHARE ANALYSIS 526
    • 15.4.4 PRODUCT PORTFOLIO 526
    • 15.4.5 RECENT DEVELOPMENT 526
  • 15.5 BIOHIT OYJ 527
    • 15.5.1 COMPANY SNAPSHOT 527
    • 15.5.2 REVENUE ANALYSIS 527
    • 15.5.3 COMPANY SHARE ANALYSIS 528
    • 15.5.4 PRODUCT PORTFOLIO 528
    • 15.5.5 RECENT DEVELOPMENT 528
  • 15.6 ACCUBIOTECH CO LTD 529
    • 15.6.1 COMPANY SNAPSHOT 529
    • 15.6.2 PRODUCT PORTFOLIO 529
    • 15.6.3 RECENT DEVELOPMENT 529
  • 15.7 ACCUQUIK TEST KITS 530
    • 15.7.1 COMPANY SNAPSHOT 530
    • 15.7.2 PRODUCT PORTFOLIO 530
    • 15.7.3 RECENT DEVELOPMENT 530
  • 15.8 AIDIAN 531
    • 15.8.1 COMPANY PROFILE 531
    • 15.8.2 PRODUCT PORTFOLIO 531
    • 15.8.3 RECENT DEVELOPMENT 531
  • 15.9 ALFA SCIENTIFIC DESIGNS, INC. 532
    • 15.9.1 COMPANY SNAPSHOT 532
    • 15.9.2 PRODUCT PORTFOLIO 532
    • 15.9.3 RECENT DEVELOPMENT 532
  • 15.10 APACOR LIMITED 533
    • 15.10.1 COMPANY SNAPSHOT 533
    • 15.10.2 PRODUCT PORTFOLIO 533
    • 15.10.3 RECENT DEVELOPMENT 533
  • 15.11 BIOPANDA REAGENTS LTD 534
    • 15.11.1 COMPANY SNAPSHOT 534
    • 15.11.2 PRODUCT PORTFOLIO 534
    • 15.11.3 RECENT DEVELOPMENT 534
  • 15.12 BODITECH MED INC. 535
    • 15.12.1 COMPANY SNAPSHOT 535
    • 15.12.2 PRODUCT PORTFOLIO 535
    • 15.12.3 RECENT DEVELOPMENT 535
Show more
  • 15.13 CENOGENICS CORPORATION 536
    • 15.13.1 COMPANY SNAPSHOT 536
    • 15.13.2 PRODUCT PORTFOLIO 536
    • 15.13.3 RECENT DEVELOPMENT 536
  • 15.14 CERTEST BIOTEC. 537
    • 15.14.1 COMPANY SNAPSHOT 537
    • 15.14.2 PRODUCT PORTFOLIO 537
    • 15.14.3 RECENT DEVELOPMENT 537
  • 15.15 CTK BIOTECH, INC. 538
    • 15.15.1 COMPANY SNAPSHOT 538
    • 15.15.2 PRODUCT PORTFOLIO 538
    • 15.15.3 RECENT DEVELOPMENT 538
  • 15.16 EDP BIOTECH 539
    • 15.16.1 COMPANY SNAPSHOT 539
    • 15.16.2 PRODUCT PORTFOLIO 539
    • 15.16.3 1.16.3 RECENT DEVELOPMENT 539
  • 15.17 EPITOPE DIAGNOSTICS, INC. 540
    • 15.17.1 COMPANY SNAPSHOT 540
    • 15.17.2 PRODUCT PORTFOLIO 540
    • 15.17.3 RECENT DEVELOPMENT 540
  • 15.18 EUROLYSER DIAGNOSTICA GMBH 541
    • 15.18.1 COMPANY SNAPSHOT 541
    • 15.18.2 PRODUCT PORTFOLIO 541
    • 15.18.3 RECENT DEVELOPMENT 541
  • 15.19 FIRSTEP 542
    • 15.19.1 COMPANY SNAPSHOT 542
    • 15.19.2 PRODUCT PORTFOLIO 542
    • 15.19.3 RECENT DEVELOPMENT 542
  • 15.20 HANGZHOU CLONGENE BIOTECH CO., LTD 543
    • 15.20.1 COMPANY SNAPSHOT 543
    • 15.20.2 PRODUCT PORTFOLIO 543
    • 15.20.3 RECENT DEVELOPMENT 543
  • 15.21 HUMASIS.COM 544
    • 15.21.1 COMPANY SNAPSHOT 544
    • 15.21.2 PRODUCT PORTFOLIO 544
    • 15.21.3 RECENT DEVELOPMENT 544
  • 15.22 JANT PHARMACAL CORPORATION 545
    • 15.22.1 COMPANY SNAPSHOT 545
    • 15.22.2 PRODUCT PORTFOLIO 545
    • 15.22.3 RECENT DEVELOPMENT 545
  • 15.23 PRIMA LAB SA 546
    • 15.23.1 COMPANY SNAPSHOT 546
    • 15.23.2 PRODUCT PORTFOLIO 546
    • 15.23.3 RECENT DEVELOPMENT 546
  • 15.24 ULTI MED PRODUCTS (DEUTSCHLAND) GMBH 547
    • 15.24.1 COMPANY SNAPSHOT 547
    • 15.24.2 PRODUCT PORTFOLIO 547
    • 15.24.3 RECENT DEVELOPMENT 547

16 QUESTIONNAIRE 548

17 RELATED REPORTS 551

LIST OF TABLES

  • TABLE 1 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 2 GLOBAL LATERAL FLOW IMMUNO-FOB TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 115
  • TABLE 3 GLOBAL IMMUNO-FOB AGGLUTINATION TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 4 GLOBAL IMMUNO-FOB ELISA TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 5 GLOBAL GUAIAC FOB STOOL TEST IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 117
  • TABLE 6 GLOBAL GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 117
  • TABLE 7 GLOBAL KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 8 GLOBAL GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 9 GLOBAL ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 10 GLOBAL SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 11 GLOBAL SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 12 GLOBAL REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 13 GLOBAL FLUSHABLE REAGENT PAD OR TISSUE IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 14 GLOBAL OTHERS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 15 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
  • TABLE 16 GLOBAL COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 127
  • TABLE 17 GLOBAL COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
  • TABLE 18 GLOBAL CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 129
  • TABLE 19 GLOBAL CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
  • TABLE 20 GLOBAL POYLPS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 130
  • TABLE 21 GLOBAL POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
  • TABLE 22 GLOBAL DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 132
  • TABLE 23 GLOBAL DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
  • TABLE 24 GLOBAL ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 134
  • TABLE 25 GLOBAL ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
  • TABLE 26 GLOBAL HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 135
  • TABLE 27 GLOBAL HEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
  • TABLE 28 GLOBAL COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 137
  • TABLE 29 GLOBAL COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
  • TABLE 30 GLOBAL ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 139
  • TABLE 31 GLOBAL ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
  • TABLE 32 GLOBAL OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 140
  • TABLE 33 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 144
  • TABLE 34 GLOBAL DIAGNOSTIC LABORATORIES IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 145
  • TABLE 35 GLOBAL HOSPITALS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 146
  • TABLE 36 GLOBAL SPECIALITY CLINICS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 146
  • TABLE 37 GLOBAL OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 147
  • TABLE 38 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 151
  • TABLE 39 GLOBAL DIRECT TENDER IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 152
  • TABLE 40 GLOBAL RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 153
  • TABLE 41 GLOBAL RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 153
  • TABLE 42 GLOBAL OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 154
  • TABLE 43 GLOBAL FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 160
  • TABLE 44 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 165
  • TABLE 45 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 46 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 165
  • TABLE 47 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 165
  • TABLE 48 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 49 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 166
  • TABLE 50 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 166
  • TABLE 51 NORTH AMERICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 52 NORTH AMERICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 166
  • TABLE 53 NORTH AMERICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 166
  • TABLE 54 NORTH AMERICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 55 NORTH AMERICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 167
  • TABLE 56 NORTH AMERICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 167
  • TABLE 57 NORTH AMERICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 58 NORTH AMERICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 167
  • TABLE 59 NORTH AMERICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 167
  • TABLE 60 NORTH AMERICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 61 NORTH AMERICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 168
  • TABLE 62 NORTH AMERICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 168
  • TABLE 63 NORTH AMERICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 64 NORTH AMERICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 168
  • TABLE 65 NORTH AMERICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 168
  • TABLE 66 NORTH AMERICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 67 NORTH AMERICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 169
  • TABLE 68 NORTH AMERICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 169
  • TABLE 69 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 169
  • TABLE 70 NORTH AMERICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170
  • TABLE 71 NORTH AMERICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170
  • TABLE 72 NORTH AMERICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170
  • TABLE 73 NORTH AMERICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 171
  • TABLE 74 NORTH AMERICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 171
  • TABLE 75 NORTH AMERICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 171
  • TABLE 76 NORTH AMERICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
  • TABLE 77 NORTH AMERICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
  • TABLE 78 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 172
  • TABLE 79 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 173
  • TABLE 80 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 81 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 174
  • TABLE 82 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 174
  • TABLE 83 U.S. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 84 U.S. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 175
  • TABLE 85 U.S. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 175
  • TABLE 86 U.S. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 87 U.S. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 175
  • TABLE 88 U.S. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 175
  • TABLE 89 U.S. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 90 U.S. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 176
  • TABLE 91 U.S. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 176
  • TABLE 92 U.S. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 93 U.S. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 176
  • TABLE 94 U.S. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 176
  • TABLE 95 U.S. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 96 U.S. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 177
  • TABLE 97 U.S. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 177
  • TABLE 98 U.S. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 99 U.S. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 177
  • TABLE 100 U.S. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 177
  • TABLE 101 U.S. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 102 U.S. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 178
  • TABLE 103 U.S. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 178
  • TABLE 104 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
  • TABLE 105 U.S. COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
  • TABLE 106 U.S. CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 179
  • TABLE 107 U.S. POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 179
  • TABLE 108 U.S. DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 179
  • TABLE 109 U.S. ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 180
  • TABLE 110 U.S. HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 180
  • TABLE 111 U.S. COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 180
  • TABLE 112 U.S. ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 181
  • TABLE 113 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 181
  • TABLE 114 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 181
  • TABLE 115 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 116 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 182
  • TABLE 117 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 182
  • TABLE 118 CANADA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 119 CANADA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 183
  • TABLE 120 CANADA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 183
  • TABLE 121 CANADA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 122 CANADA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 183
  • TABLE 123 CANADA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 183
  • TABLE 124 CANADA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 125 CANADA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 184
  • TABLE 126 CANADA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 184
  • TABLE 127 CANADA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 128 CANADA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 184
  • TABLE 129 CANADA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 184
  • TABLE 130 CANADA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 131 CANADA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 185
  • TABLE 132 CANADA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 185
  • TABLE 133 CANADA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 134 CANADA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 185
  • TABLE 135 CANADA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 185
  • TABLE 136 CANADA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 137 CANADA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 186
  • TABLE 138 CANADA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 186
  • TABLE 139 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 186
  • TABLE 140 CANADA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 186
  • TABLE 141 CANADA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 187
  • TABLE 142 CANADA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 187
  • TABLE 143 CANADA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 187
  • TABLE 144 CANADA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 188
  • TABLE 145 CANADA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 188
  • TABLE 146 CANADA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 188
  • TABLE 147 CANADA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 189
  • TABLE 148 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 189
  • TABLE 149 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 189
  • TABLE 150 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 151 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 190
  • TABLE 152 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 190
  • TABLE 153 MEXICO GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 154 MEXICO GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 191
  • TABLE 155 MEXICO GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 191
  • TABLE 156 MEXICO KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 157 MEXICO KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 191
  • TABLE 158 MEXICO KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 191
  • TABLE 159 MEXICO GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 160 MEXICO GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 192
  • TABLE 161 MEXICO GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 192
  • TABLE 162 MEXICO ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 163 MEXICO ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 192
  • TABLE 164 MEXICO ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 192
  • TABLE 165 MEXICO SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 166 MEXICO SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 193
  • TABLE 167 MEXICO SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 193
  • TABLE 168 MEXICO SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 169 MEXICO SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 193
  • TABLE 170 MEXICO SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 193
  • TABLE 171 MEXICO REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 172 MEXICO REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 194
  • TABLE 173 MEXICO REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 194
  • TABLE 174 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 194
  • TABLE 175 MEXICO COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 194
  • TABLE 176 MEXICO CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 195
  • TABLE 177 MEXICO POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 195
  • TABLE 178 MEXICO DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 195
  • TABLE 179 MEXICO ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 196
  • TABLE 180 MEXICO HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 196
  • TABLE 181 MEXICO COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 196
  • TABLE 182 MEXICO ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 197
  • TABLE 183 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 197
  • TABLE 184 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 197
  • TABLE 185 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 202
  • TABLE 186 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 202
  • TABLE 187 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 202
  • TABLE 188 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 203
  • TABLE 189 ASIA-PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 203
  • TABLE 190 ASIA-PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 203
  • TABLE 191 ASIA-PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 203

LIST OF FIGURES

  • FIGURE 1 GLOBAL FECAL OCCULT BLOOD TESTSMARKET: SEGMENTATION 81
  • FIGURE 2 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: DATA TRIANGULATION 84
  • FIGURE 3 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: DROC ANALYSIS 85
  • FIGURE 4 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 86
  • FIGURE 5 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: COMPANY RESEARCH ANALYSIS 86
  • FIGURE 6 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: INTERVIEW DEMOGRAPHICS 87
  • FIGURE 7 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: MARKET APPLICATION COVERAGE GRID 89
  • FIGURE 8 GLOBAL FECAL OCCULT BLOOD TESTSMARKET: DBMR MARKET POSITION GRID 90
  • FIGURE 9 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: VENDOR SHARE ANALYSIS 91
  • FIGURE 10 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: SEGMENTATION 94
  • FIGURE 11 RISING CASES OF COLORECTAL CANCER GLOBALLY AND EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL FECAL OCCULT BLOOD TESTS MARKET FROM 2023 TO 2030 95
  • FIGURE 12 THE LATERAL FLOW IMMUNO-FOB, TEST KITS SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL FECAL OCCULT BLOOD TESTS MARKET IN 2023 & 2030 95
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL FECAL OCCULT BLOOD TESTS MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 96
  • FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR FECAL OCCULT BLOOD TESTS MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030 97
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL FECAL OCCULT BLOOD TESTS MARKET 105
  • FIGURE 16 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2022 112
  • FIGURE 17 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 113
  • FIGURE 18 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, CAGR (2023-2030) 113
  • FIGURE 19 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, LIFELINE CURVE 114
  • FIGURE 20 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2022 124
  • FIGURE 21 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 125
  • FIGURE 22 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, CAGR (2023-2030) 125
  • FIGURE 23 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, LIFELINE CURVE 126
  • FIGURE 24 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2022 142
  • FIGURE 25 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2023-2030 (USD MILLION) 143
  • FIGURE 26 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY END USER, CAGR (2023-2030) 143
  • FIGURE 27 GLOBAL FECAL OCCULT BLOOD TESTS MARKET : BY END USER, LIFELINE CURVE 144
  • FIGURE 28 GLOBAL FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2022 149
  • FIGURE 29 GLOBAL FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 150
  • FIGURE 30 GLOBAL FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 150
  • FIGURE 31 GLOBAL FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 151
  • FIGURE 32 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 157
  • FIGURE 33 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY REGION (2022) 158
  • FIGURE 34 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY REGION (2023 & 2030) 158
  • FIGURE 35 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY REGION (2022 & 2030) 159
  • FIGURE 36 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE (2023-2030) 159
  • FIGURE 37 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 162
  • FIGURE 38 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 163
  • FIGURE 39 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 163
  • FIGURE 40 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 164
  • FIGURE 41 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE (2023-2030) 164
  • FIGURE 42 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 199
  • FIGURE 43 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 200
  • FIGURE 44 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 200
  • FIGURE 45 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022 & 2030) 201
  • FIGURE 46 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE (2023-2030) 201
  • FIGURE 47 EUROPE FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 297
  • FIGURE 48 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 298
  • FIGURE 49 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 298
  • FIGURE 50 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 299
  • FIGURE 51 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE (2023-2030) 299
  • FIGURE 52 SOUTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 413
  • FIGURE 53 SOUTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 414
  • FIGURE 54 SOUTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 414
  • FIGURE 55 SOUTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022 & 2030) 415
  • FIGURE 56 SOUTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: TEST TYPE (2023-2030) 415
  • FIGURE 57 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 449
  • FIGURE 58 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 450
  • FIGURE 59 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 450
  • FIGURE 60 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022 & 2030) 451
  • FIGURE 61 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: TEST TYPE (2023-2030) 451
  • FIGURE 62 GLOBAL FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 514
  • FIGURE 63 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 515
  • FIGURE 64 EUROPE FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 516
  • FIGURE 65 AISA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 517
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!